3D Cardiac Mapping Systems Market Size (2024 - 2029)

3D Cardiac Mapping Systems Market Analysis

The 3D Cardiac Mapping Systems Market size is estimated at USD 538.60 million in 2024, and is expected to reach USD 924.07 million by 2029, growing at a CAGR of 11.40% during the forecast period (2024-2029).

The major factors driving the market are the rising prevalence of cardiovascular diseases coupled with the rising geriatric population, the increasing technological advancements, and growing government organizations' initiatives to create awareness about cardiovascular diseases.

The rising prevalence of cardiovascular diseases coupled with the rising geriatric population is expected to drive demand for the 3D cardiac mapping system to diagnose cardiovascular diseases such as tachyarrhythmias and atrial fibrillation, which is expected to drive the market during the forecast period. For instance, according to an article published in the Lancet in February 2024, atrial fibrillation (AF) was more prevalent, with a lifetime risk of about 1 in 3-5 individuals after the age of 45 years. Projection studies reported that the prevalence of AF is expected to rise to 15.9 million in 2050 in America and 17.9 million in 2060 in Europe.

Similarly, according to StatPearls updated data from July 2023, ventricular tachycardia is strongly associated with coronary artery disease; around 15% of patients with coronary artery disease have ventricular tachycardia. Hence, the significant prevalence of cardiovascular diseases is expected to drive the market's growth during the forecast period.

The increasing technological advancements in 3D cardiac mapping systems are expected to increase the adoption of this system for diagnosing various diseases, which will ultimately drive the growth of the market during the forecast period. For instance, according to an article published in the Frontiers in April 2023, fluoroscopy integrated 3D mapping. A new 3D non-fluoroscopic navigation system software (CARTO Univu Module) was integrated into the 3D mapping systems to reduce radiation exposure during radiofrequency catheter ablation (RFCA). Hence, such incorporation of navigation software in cardiac mapping systems is expected to drive the growth of the market during the forecast period.

Also, according to an article published in October 2022, 3D nuclear imaging was integrated into the 3D mapping system to identify low-voltage proarrhythmic areas for catheter ablation of scar-mediated ventricular tachycardia (VT). Hence, such technological advancements are expected to drive the market during the forecast period.

Thus, the above-mentioned factors, including the rising prevalence of cardiovascular diseases and increasing technological advancements in 3D mapping systems, are expected to drive the growth of the market during the forecast period. However, the high cost of 3D cardiac mapping systems is expected to restrain the market during the forecast period.

3D Cardiac Mapping Systems Industry Segmentation

As per the scope of the report, 3D cardiac mapping system devices use mapping catheters to measure the electrical activity of cardiac tissue and create comprehensive three-dimensional electroanatomic mapping of your patients’ hearts. The 3D cardiac mapping system market is segmented into technology, end user, and geography. By technology, the market is segmented into electroanatomical mapping, basket catheter mapping, and real-time positional management. By end user, the market is segmented into hospitals, clinics, and diagnostic centers. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. For each segment, the market sizing and forecasts are done based on value (in USD).